• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, September 20, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News

Media can register now for ESTRO 36 – Europe’s largest congress on radiation oncology

Bioengineer by Bioengineer
March 1, 2017
in Science News
Reading Time: 1 min read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Registration has now opened for journalists for ESTRO 36 – Europe's largest congress on radiation oncology, organised by the European Society for Radiotherapy and Oncology (ESTRO).

ESTRO 36 takes place at the Reed Messe Vienna GmbH, Congress Centre, Messeplatz 1, A-1021 Vienna, Austria, 5 – 9 May 2017. Registration is free for journalists on provision of bona fide press credentials.

The ESTRO 36 congress will feature new research results in clinical radiation oncology, radiobiology, physics, technology, patient care, radiation therapy and brachytherapy, presented by top doctors, scientists, radiation therapists and cancer nurses from all over the world, working together for the benefit of cancer patients.

The congress is expected to attract 5,000 delegates from more than 80 countries.

The congress will cover the entire spectrum of radiotherapy, both external beam and internal beam with brachytherapy, and highlight what is new across fields as diverse as:

  • state-of-the-art breast brachytherapy
  • combination radiotherapy and targeted agents
  • radiotherapy and health economics
  • how to select the right patients for proton therapy in Europe
  • emerging technologies in particle therapy
  • long-term effects in cancer survivors
  • targeted therapy, stem cells, and normal tissue toxicity

###

The ESTRO web site has full details about ESTRO 36, including the scientific programme, venue, accommodation, media registration etc.

Twitter hashtag: #ESTRO36

Media Contact

Cécile Hardon-Villard
[email protected]

http://www.estro.org/Pages/default.aspx

############

Story Source: Materials provided by Scienmag

Share12Tweet7Share2ShareShareShare1

Related Posts

Hydrocortisone Use in Extremely Preterm Infants

September 20, 2025

Standardized Extract Boosts Immunity in Chemotherapy Mice

September 20, 2025

Reticulocalbin-1: Biomarker and Therapy Target in RCC

September 20, 2025

Ag-Doped MnO2 Sea Urchin Structure Boosts Zinc Batteries

September 20, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    156 shares
    Share 62 Tweet 39
  • Physicists Develop Visible Time Crystal for the First Time

    67 shares
    Share 27 Tweet 17
  • Tailored Gene-Editing Technology Emerges as a Promising Treatment for Fatal Pediatric Diseases

    49 shares
    Share 20 Tweet 12
  • Scientists Achieve Ambient-Temperature Light-Induced Heterolytic Hydrogen Dissociation

    48 shares
    Share 19 Tweet 12

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Hydrocortisone Use in Extremely Preterm Infants

Standardized Extract Boosts Immunity in Chemotherapy Mice

Reticulocalbin-1: Biomarker and Therapy Target in RCC

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.